Beta Drugs Ltd

NSE: BETA · BSE: 531481 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹1,871.00
Market cap: ₹2,074 Cr
Revenue (annual): ₹384.8 Cr
Net profit (annual): ₹41.48 Cr
P/E (TTM): 40.0×Sector 43.8×
Promoter holding: 58.91%-0.19% QoQ
FII holding: 1.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Earnings Call 2 Board Meeting Date 2 Annual General Meeting 2 Management Change 1 Financial Results 1 Capital Structure Change 1 Business Update 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Sep 2026 11:35 IST NSE

Annual General Meeting

Beta Drugs Annual General Meeting

Beta Drugs Limited conducted its 21st Annual General Meeting on September 30, 2026. Shareholders considered resolutions including financial statement adoption, director re-appointments, and auditor ratification.

Open announcement → Read the filing ↗

3 Sep 2026 18:04 IST NSE

Annual General Meeting

Beta Drugs Annual General Meeting

Beta Drugs Limited has scheduled its 21st Annual General Meeting for September 30, 2026, at its registered office in Baddi, Himachal Pradesh.

Open announcement → Read the filing ↗